KALV SG&A Expenses

Kalvista Pharmaceuticals Inc · SG&A Expenses

KALV logo

KALV SG&A Expenses

Latest reported$198.25M
KALV SG&A Expenses ($1.41M → $198.25M)
High-resolution chart · PNG

KALV sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kalvista Pharmaceuticals Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
183,741,000
116,286,000
54,278,000
30,595,000
26,446,000
16,637,000
13,029,000
10,926,000
8,862,000
11,177,000
2,653,000
1,608,000
1,402,000
1,412,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.